Introduction {#Sec1}
============

Acute kidney injury (AKI) is common after cardiac surgery and is a strong predictor of morbidity and mortality \[[@CR1]\]. Hyperphosphatemia following AKI, by renal excretion defect, has never been studied in this context and could be a simple marker of AKI.

Objectives {#Sec2}
==========

The aim of this study was to assess the predictability of serum phosphorus (Ph) for AKI monitoring after cardiac surgery.

Methods {#Sec3}
=======

In this retrospective diagnostic validation study of 547 patients admitted in our institute between January 2012 and December 2012, we excluded patients with end stage renal disease (clearance \< 15mL / min / 1.73m2) or dialyzed, solitary kidney or nephrectomy, lack of data. Serum creatinine (Cr) and Ph were measured preoperatively and postoperatively specifically (H0, H12, H24, H48, H72). The percentage of maximum elevation of Ph (%EPh = \[(maximum -minimum) / minimum\] \* 100) was calculated. AKI was defined as an increase Cr more than 26.5 mmol / L in 48 hours according to KDIGO criteria \[[@CR2]\].The diagnostic performance of postoperative Ph thresholds were analysed by elaborating area under the receiver operating characteristic curves (AUC-ROC) with sensitivity (Se), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV).

Results {#Sec4}
=======

From the 386 patients included, the mean Euroscore II was 4.2 ± 6.3%, SAPS II score, 26.4 ± 10.8. Among them, 21.2% developed AKI (grade 1: 13.2%, grade 2: 4.1%, grade 3: 3.1%) and 2.6% required renal replacement therapy (RRT). Patients with AKI had Euroscore II, duration of cardiopulmonary bypass, transfusion needing and mortality higher than those without AKI (p \< 0.001). The %EPh and the Ph at 48 hours (Ph~48H~) were significantly higher in AKI patients than in no AKI patients: 81 ± 79% and 1.47 ± 0.46 mmol/l *vs* 25 ± 23% and 0.99 ± 0.2 mmol/L, respectively (p \< 0.001). A value of Ph~48H~ \> 1.19 mmol/L ( Se 72% (60-82), Sp 84% (71-92), PPV 84%, NPV 72%) and a %EPh \> 49 % (Se 73% (61-81), Sp 83% (76-88), PPV 66%, NPV 86%) were predictive of AKI. In AKI patients, the %EPh and Ph~48H~ significantly increased with the severity of AKI (Table [1](#Tab1){ref-type="table"}). In these patients, a Ph~48H~ \< 1.53 mmol/L and a %EPh \< 77% predicted the non use of RRT (Se 100% (62-100), Sp 85% (77-91), PPV 35% NPV 100%), respectively (Table [2](#Tab2){ref-type="table"}).Table 1AKI severity%EPhPh~48H~ (mmol/L)Grade 160 ± 451.25 ± 0.4Grade 274 ± 581.73 ± 0.4Grade 3159 ± 1321.80 ± 0.5Table 2ThresholdsAUC (IC95% )*p value*AKI diagnosticPh~48H~1.19 mmol/L0.813 (0.735-0.890)\< 0.0001%EPh49%0.830 (0.772-0.889)\< 0.0001RRT requiringPh~48H~1.53 mmol/L0.924 (0.879-0.970)\< 0.0001%EPh77%0.818 (0.683-0.952)\< 0.0001

Conclusions {#Sec5}
===========

After cardiac surgery, serum phosphorus seems to be a simple, reliable and inexpensive biomarker at bedside for AKI monitoring. A value less than 1.53 mmol/L at 48h may predict the no-initiation of RRT in case of AKI and may guide the clinician to a non-invasive-AKI therapeutic. Obviously, these results should be interpreted with caution regarding the retrospective nature of the study.
